New drug could be a breakthrough in treatment for killer TB . . . A decade ago, patients with drug-resistant tuberculosis faced a gruelling treatment regimen of 18 months or more, involving multiple injections and hospital stays, that only cured about 50% of people The current goldstandard treatment, introduced in 2019, successfully treats 90% of people within six months
The Guardian We would like to show you a description here but the site won’t allow us
Sorbequiline, a new antibiotic likely to serve as a . . . - MSN US foreign aid cuts could trigger additional 22 lakh deaths in high-burden TB countries, reveals Study Sorbequiline, a new antibiotic likely to serve as a breakthrough in Tuberculosis treatment
New Antibiotic Could Be a Breakthrough in Treatment for . . . New Antibiotic Could Be a Breakthrough in Treatment for Killer TB, Trial Suggests (theguardian com) 15 Posted by msmash on Wednesday November 19, 2025 @03:42PM from the encouraging-signs dept
New Drug Could Be a Breakthrough in Treatment for Killer TB . . . A new antibiotic named Sorfequiline has demonstrated promising results in clinical trials as a potent treatment for Tuberculosis (TB) The drug is shown to be stronger than existing treatments and could potentially be effective against drug-resistant strains of the deadly bacteria